GO:0002172 high-affinity IgM receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002172 high-affinity IgM receptor activity describes a molecular function in which a receptor binds IgM via its Fc region with high affinity and transmits a signal across the membrane.
• The best-characterized high-affinity IgM receptor is FcμR (FCMR/TOSO), which binds the Fc portion of human IgM and is expressed on B and T lineage cells [1,7].
• In murine B cells, cross-linking of IgM receptors rapidly recruits Ig alpha, Lyn, and Syk tyrosine kinases to the membrane skeleton, initiating downstream signaling.
• Signaling outcomes depend on antibody avidity: high-avidity anti-IgM can drive proliferation or growth inhibition/tolerance in immature B cell lymphomas.
• The poly-Ig receptor can also bind IgA and IgM in some murine B cell lymphoma contexts, showing that IgM recognition is not limited to one receptor family.
• Engineered Fc receptor variants, such as modified FcγRI, demonstrate that Fc-mediated recognition can be reprogrammed for robust tumor-specific cytotoxicity.
Description
GO:0002172 high-affinity IgM receptor activity is a molecular function defined by the high-affinity binding of an IgM isotype antibody through its Fc region, followed by transmission of a signal from one side of the membrane to the other to initiate a change in cell activity. This term captures the receptor side of IgM biology, distinguishing it from soluble IgM effector functions and from low-affinity IgM interactions. Researchers studying B cell activation, tolerance, and humoral immunity need this term because IgM is the first antibody isotype produced in an immune response, and its receptor-mediated recognition shapes B cell fate decisions [4,6]. The function is experimentally tractable: binding-site mapping for FcμR in human IgM-Fc has defined the molecular interface required for high-affinity recognition, while cross-linking studies have resolved the proximal signaling machinery recruited by IgM receptors in B cells. Beyond classical immunology, high-affinity IgM receptor activity is relevant to engineered immune cell therapies, where Fc receptor variants can redirect cytotoxic function. This article integrates the QuickGO definition with verified PubMed literature to provide a research-grade overview of the mechanism, genes, disease links, and CRISPR-based methods used to study GO:0002172.
high-affinity IgM receptor activity At A Glance
| GO ID | GO:0002172 |
|---|---|
| GO term | high-affinity IgM receptor activity |
| Ontology | molecular_function |
| Synonym | high affinity IgM receptor activity |
| Major function | High-affinity binding of IgM via the Fc region and transmission of a signal across the membrane to initiate a change in cell activity |
| Best-characterized receptor | FcμR (FCMR/TOSO), which binds human IgM-Fc with high affinity |
| Proximal signaling machinery | Ig alpha, Lyn, and Syk tyrosine kinases are recruited to the membrane skeleton after IgM receptor cross-linking |
| Related receptor family | Poly-Ig receptor can bind IgA/IgM in murine B cell lymphoma |
| Signaling outcome | Avidity-dependent proliferation versus growth inhibition/tolerance in immature B cell lymphoma |
What Is GO:0002172?
In simple terms, GO:0002172 high-affinity IgM receptor activity is the ability of a cell-surface receptor to grab onto the Fc region of an IgM antibody tightly and then send a signal into the cell. The QuickGO definition specifies three elements: (1) combining with high affinity with an immunoglobulin of the IgM isotype via the Fc region; (2) transmitting the signal from one side of the membrane to the other; and (3) initiating a change in cell activity. This is a molecular_function term, so it describes what the receptor does at the molecular level rather than a whole pathway or cellular location. The synonym high affinity IgM receptor activity is equivalent. The term should not be confused with generic IgM binding or with Fc receptor activity for other isotypes such as IgG; the high-affinity and IgM-isotype constraints are essential. Experimentally, the function is often assayed by measuring binding of IgM-Fc to candidate receptors and by detecting downstream phosphorylation events after receptor cross-linking [1,4].
Why Is high-affinity IgM receptor activity Important in Cell Biology?
GO:0002172 high-affinity IgM receptor activity matters because IgM is the first antibody isotype produced during an immune response, and its receptor-mediated recognition directly influences B cell activation, tolerance, and survival decisions [4,6]. Defects or dysregulation in this function can shift the balance between productive immunity and autoreactivity, making it a focal point for understanding humoral immune regulation. The function is also important for translational immunology: engineered Fc receptor variants that redirect cytotoxic cells toward tumors demonstrate the therapeutic potential of manipulating Fc-mediated recognition. In addition, the poly-Ig receptor can bind IgA/IgM in some B cell contexts, indicating that IgM recognition intersects with mucosal and secretory immunoglobulin biology. For researchers, the term provides a precise ontological anchor for annotating receptors, designing binding assays, and interpreting signaling data from B and T lineage cells [1,7].
• Defines the receptor-side molecular function for IgM, the first antibody isotype in humoral immunity.
• Controls B cell fate decisions such as proliferation versus tolerance/growth inhibition in an avidity-dependent manner.
• Provides a mechanistic entry point for studying B cell receptor-proximal signaling through Ig alpha, Lyn, and Syk.
• Enables precise annotation of FcμR/FCMR and related IgM-binding receptors in genomic and proteomic datasets.
• Connects to mucosal immunity because the poly-Ig receptor can bind IgA/IgM in murine B cell lymphoma.
• Supports engineering of Fc receptor variants for tumor-specific cytotoxicity.
• Relevant to T lymphocyte biology because Fc receptors for IgM have been described on activated human T lymphocytes.
• Guides binding-site mapping and structure-function studies of IgM-Fc/receptor interfaces.
• Informs therapeutic strategies that target IgM-mediated signaling in autoimmune and lymphoproliferative contexts.
• Offers a defined molecular_function term for CRISPR screens and functional genomics of immune receptors [1,4].
Mechanism, Genes and Research Methods of GO:0002172
What Happens During high-affinity IgM receptor activity?
In simple terms: A receptor on the cell surface catches IgM tightly and then sends a signal inside the cell.
The biological process begins with high-affinity recognition of the IgM Fc region by a cell-surface receptor. This binding event is the defining trigger for GO:0002172. In B lineage cells, cross-linking of IgM receptors leads to rapid translocation of IgM-associated Ig alpha, Lyn, and Syk tyrosine kinases to the membrane skeleton, which is an early step in signal propagation. The strength of this signal can be modulated by antibody avidity, and in immature B cell lymphoma, high-avidity anti-IgM can drive either proliferation or growth inhibition/tolerance. Thus, the process converts extracellular IgM recognition into intracellular signaling outcomes that depend on receptor occupancy and avidity.
Receptor cross-linking and membrane skeleton recruitment
In simple terms: When several IgM receptors are grouped together, signaling proteins move to the membrane skeleton to start the signal.
Cross-linking of the IgM receptor induces rapid translocation of IgM-associated Ig alpha, Lyn, and Syk tyrosine kinases to the membrane skeleton. This recruitment is a hallmark of proximal IgM receptor signaling and provides a measurable readout for functional studies of GO:0002172. The membrane skeleton acts as a scaffold that concentrates kinases and adaptors, facilitating phosphorylation cascades. Researchers can assay this step by cross-linking surface IgM and detecting Ig alpha, Lyn, and Syk in membrane skeleton fractions.
Avidity-dependent signaling outcomes
In simple terms: How tightly and how many IgM molecules are grouped determines whether B cells grow or stop growing.
The influence of avidity on signaling murine B lymphocytes with monoclonal anti-IgM antibodies has been directly tested, showing effects on B cell proliferation versus growth inhibition (tolerance) of an immature B cell lymphoma. This demonstrates that GO:0002172 is not a simple on/off switch; the valency and affinity of the IgM ligand shape the downstream response. For researchers, this means that experimental design must control antibody avidity when interpreting IgM receptor function.
Structure and Composition of high-affinity IgM receptor activity
In simple terms: The receptor is a membrane protein that binds IgM, often with associated signaling subunits.
The best-characterized high-affinity IgM receptor is FcμR (FCMR/TOSO), and mapping of the binding site for FcμR in human IgM-Fc has defined the structural interface required for recognition. In murine B cells, the IgM receptor complex is associated with Ig alpha, Lyn, and Syk, which are recruited to the membrane skeleton upon cross-linking. The poly-Ig receptor represents an additional IgA/IgM-binding receptor expressed on a murine B cell lymphoma, showing that multiple receptor architectures can support IgM recognition. Fc receptors for IgM have also been described on activated human T lymphocytes, indicating that the function is not restricted to B cells.
Molecular Mechanism of high-affinity IgM receptor activity
In simple terms: The receptor binds the Fc part of IgM and then activates kinases inside the cell.
At the molecular level, GO:0002172 requires high-affinity binding to the IgM Fc region. This binding is followed by transmission of the signal across the membrane, which in B cells involves Ig alpha, Lyn, and Syk tyrosine kinases. The kinase recruitment to the membrane skeleton is a key catalytic/regulatory step because Lyn and Syk are tyrosine kinases that propagate phosphorylation signals. Antibody avidity modulates the strength of this mechanism, as shown by differential effects on proliferation versus tolerance. The molecular function is therefore best described as a receptor-proximal recognition and signaling event rather than an enzymatic catalysis of a small-molecule substrate.
Regulation and engineering of IgM receptor signaling
In simple terms: The signal can be tuned by how the receptor is engaged and can be reprogrammed by engineering.
Regulation of GO:0002172 occurs at the level of ligand avidity and receptor cross-linking, which determine whether B cells proliferate or undergo growth inhibition/tolerance. The poly-Ig receptor can also bind IgA/IgM, adding a layer of isotype cross-reactivity in some B cell contexts. Engineering approaches show that Fc receptor specificity can be modified: expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity, demonstrating that Fc-mediated recognition is engineerable. These findings support the use of CRISPR-based receptor engineering to dissect and reprogram high-affinity IgM receptor activity.
Key Genes Involved in GO:0002172 high-affinity IgM receptor activity
The following genes and proteins are directly implicated in high-affinity IgM receptor activity, its proximal signaling, or related Fc receptor biology according to the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FCMR (FcμR/TOSO) | High-affinity receptor for the Fc region of IgM | Binding-site mapping and receptor function studies |
| IGHM | Encodes the IgM heavy chain containing the Fc region recognized by the receptor | Source of IgM-Fc ligand for binding assays |
| CD79A (Ig alpha) | IgM-associated signaling subunit recruited to membrane skeleton after cross-linking | Proximal signaling readout in B cells |
| LYN | Src-family tyrosine kinase recruited to membrane skeleton after IgM receptor cross-linking | Kinase activation assays |
| SYK | Tyrosine kinase recruited to membrane skeleton after IgM receptor cross-linking | Downstream phosphorylation studies |
| PIGR (poly-Ig receptor) | Can bind IgA/IgM in murine B cell lymphoma | Isotype cross-reactivity studies |
| FCGR1 (FcγRI) | Fc receptor whose modified form enables tumor-specific cytotoxicity | Fc receptor engineering |
| PAX5 | B lineage transcription factor studied in IgH 3' enhancer activation | B cell transcriptional regulation |
| IgH 3' enhancer | Regulatory element activated in B lineage cells | Transcriptional control of immunoglobulin genes |
| T cell FcμR | Fc receptor for IgM on activated human T lymphocytes | T cell activation marker studies |
| Anti-IgM antibodies | Experimental ligands that cross-link IgM receptors | Avidity-dependent signaling assays |
| Immature B cell lymphoma model | System for testing proliferation versus tolerance | Functional IgM signaling studies |
| Murine B cell lymphoma | Expresses IgA/IgM poly-Ig receptor | Receptor characterization |
| Myeloid cells | Engineered to express modified FcγRI for cytotoxicity | Cellular immunotherapy research |
| Activated T lymphocytes | Express Fc receptors for IgG and IgM | Human T cell immunology |
| IgM-Fc fragment | Ligand used to map FcμR binding site | Structural and binding studies |
| Membrane skeleton | Scaffold for Ig alpha, Lyn, and Syk recruitment | Biochemical fractionation assays |
How Is high-affinity IgM receptor activity Regulated?
Regulation of high-affinity IgM receptor activity is primarily governed by ligand avidity and receptor cross-linking. The influence of avidity on signaling murine B lymphocytes with monoclonal anti-IgM antibodies determines whether B cells proliferate or undergo growth inhibition/tolerance in an immature B cell lymphoma. In addition, the poly-Ig receptor can bind IgA/IgM, indicating that isotype competition or cross-reactivity may modulate IgM-specific signaling in some B cell contexts. Transcriptional regulation of immunoglobulin genes in B lineage cells involves the IgH 3' enhancer, and Pax-5 studies have examined its activation. These layers of regulation mean that experimental measurements of GO:0002172 must account for ligand valency, receptor density, and B cell developmental stage.
high-affinity IgM receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FCMR (FcμR/TOSO) | IgM-mediated B cell signaling and immune regulation | Knockout B cell lines and binding assays |
| LYN | B cell lymphoma and tolerance signaling [4,6] | Point-mutation kinase-dead models |
| SYK | B cell activation and lymphoproliferative disease | Knockout and knock-in reporter models |
| PIGR | Mucosal immunity and IgA/IgM transport | Overexpression in B cell lymphoma lines |
| FCGR1 | Cancer immunotherapy | Engineered myeloid cell cytotoxicity assays |
B cell lymphoma and tolerance
High-affinity IgM receptor activity is directly linked to B cell fate in lymphoma models. In an immature B cell lymphoma, the avidity of anti-IgM antibodies determines whether signaling drives proliferation or growth inhibition/tolerance. This makes GO:0002172 relevant to understanding lymphoproliferative disorders and the mechanisms by which immature B cells are eliminated or escape tolerance.
Cancer immunotherapy and engineered Fc receptors
Fc receptor biology is being harnessed for cancer therapy. Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity. Although this involves an IgG receptor, it demonstrates the principle that Fc-mediated recognition can be engineered for therapeutic benefit, providing a conceptual bridge to high-affinity IgM receptor activity.
Autoimmunity and mucosal immunity
The poly-Ig receptor can bind IgA/IgM in murine B cell lymphoma, linking IgM recognition to mucosal and secretory immunoglobulin pathways. Dysregulation of IgM receptor signaling could therefore contribute to autoimmune or mucosal immune disorders, although direct disease associations require further study.
From high-affinity IgM receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of FCMR abolish high-affinity IgM binding? | FCMR knockout cell line |
| Which residues mediate IgM-Fc binding? | Point-mutation knock-in of FCMR binding site |
| How does IgM receptor cross-linking recruit Lyn and Syk? | Tagged knock-in of Lyn/Syk with membrane skeleton fractionation |
| Does antibody avidity shift proliferation versus tolerance? | Immature B cell lymphoma treated with anti-IgM of varying avidity |
| Can Fc receptor specificity be reprogrammed for cytotoxicity? | Overexpression of modified FcγRI in myeloid cells |
| Is the poly-Ig receptor sufficient for IgM recognition? | Overexpression of PIGR in B cell lymphoma |
How to Study the high-affinity IgM receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| IgM-Fc binding assay | Affinity and specificity of receptor-IgM interaction | Validating high-affinity IgM receptor candidates |
| Membrane skeleton fractionation | Recruitment of Ig alpha, Lyn, and Syk | Proximal signaling studies |
| Phospho-kinase immunoblot | Activation of Lyn and Syk | Signaling pathway analysis |
| Anti-IgM avidity titration | Proliferation versus tolerance | B cell fate assays |
| Fc receptor cytotoxicity assay | Tumor-specific killing by engineered myeloid cells | Immunotherapy engineering |
| Flow cytometry | Surface expression of Fc receptors on T and B cells | Immunophenotyping |
| Transcriptional reporter assay | IgH 3' enhancer activation in B lineage cells | B cell transcriptional regulation |
Binding assays for IgM-Fc recognition
Mapping of the binding site for FcμR in human IgM-Fc provides a template for assaying high-affinity IgM receptor activity. Recombinant IgM-Fc fragments and surface plasmon resonance or ELISA-based binding assays can quantify affinity and specificity. These methods are essential for confirming that a candidate receptor meets the high-affinity criterion of GO:0002172.
Proximal signaling assays
Cross-linking of the IgM receptor induces rapid translocation of IgM-associated Ig alpha, Lyn, and Syk tyrosine kinases to the membrane skeleton. Researchers can use membrane skeleton fractionation followed by immunoblotting to measure this recruitment. Phospho-specific antibodies against Lyn and Syk provide additional readouts of kinase activation.
Avidity-dependent functional assays
The influence of avidity on signaling murine B lymphocytes with monoclonal anti-IgM antibodies can be tested by treating cells with antibodies of different valency and measuring proliferation versus growth inhibition. This approach is critical for linking GO:0002172 to functional outcomes in B cell lymphoma models.
Engineered Fc receptor cytotoxicity assays
Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity, providing a method to test engineered Fc receptor function. Similar assays can be adapted to IgM receptor variants to evaluate signaling and effector outcomes.
How CRISPR Can Be Used to Study GO:0002172 high-affinity IgM receptor activity
Knockout
CRISPR knockout of FCMR or signaling components such as LYN and SYK can test whether high-affinity IgM receptor activity is required for downstream responses [1,4]. Loss-of-function models are essential for establishing causality between receptor expression and IgM-mediated signaling.
Point Mutation
Point mutations in the IgM-Fc binding site of FCMR can be introduced to map residues required for high-affinity recognition. Such models allow precise structure-function dissection without confounding effects from complete protein loss.
Knock-in
Tagged knock-in of Ig alpha, Lyn, or Syk enables tracking of their recruitment to the membrane skeleton after IgM receptor cross-linking. Knock-in reporters can also be used to monitor transcriptional activation of immunoglobulin enhancers in B lineage cells.
Overexpression
Overexpression of FCMR, PIGR, or modified FcγRI can test sufficiency of these receptors for IgM binding and signaling [1,2,3]. Overexpression models are particularly useful for engineering Fc receptor specificity and evaluating cytotoxic potential.
How EDITGENE Supports high-affinity IgM receptor activity Research
Researchers studying high-affinity IgM receptor activity-related genes often need to determine whether a candidate gene is causally involved in IgM recognition, proximal signaling, or downstream B cell fate decisions. EDITGENE provides CRISPR-based cell model services that enable precise genetic perturbations, from complete knockout to single-base point mutations and tagged knock-ins, allowing functional validation of GO:0002172-associated genes in relevant immune cell backgrounds.
Contact EDITGENE today to design your custom CRISPR model for high-affinity IgM receptor activity research.
Frequently Asked Questions About high-affinity IgM receptor activity
What is high-affinity IgM receptor activity?
It is the molecular function defined by GO:0002172, in which a receptor binds the Fc region of IgM with high affinity and transmits a signal across the membrane to initiate a change in cell activity.
What genes are involved in high-affinity IgM receptor activity?
Key genes include FCMR (FcμR/TOSO), which encodes the high-affinity IgM receptor, and signaling components such as CD79A (Ig alpha), LYN, and SYK [1,4].
Which receptor binds IgM with high affinity?
FcμR (FCMR/TOSO) is the best-characterized high-affinity receptor for the Fc region of human IgM.
What happens after IgM receptor cross-linking?
Cross-linking induces rapid translocation of IgM-associated Ig alpha, Lyn, and Syk tyrosine kinases to the membrane skeleton.
How does antibody avidity affect IgM receptor signaling?
Avidity influences whether murine B lymphocytes proliferate or undergo growth inhibition/tolerance in an immature B cell lymphoma model.
Is the poly-Ig receptor an IgM receptor?
The IgA/IgM receptor expressed on a murine B cell lymphoma is poly-Ig receptor, indicating that it can bind IgM in some contexts.
Are there IgM receptors on T cells?
Yes, Fc receptors for IgM have been described on activated human T lymphocytes.
Can Fc receptor specificity be engineered?
Yes, expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity, demonstrating engineerability of Fc recognition.
What diseases are linked to high-affinity IgM receptor activity?
It is linked to B cell lymphoma biology and tolerance, and conceptually to cancer immunotherapy through engineered Fc receptors [3,6].
How can CRISPR help study high-affinity IgM receptor activity?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of FCMR, LYN, SYK, and related genes in IgM signaling [1,4].
Conclusion
GO:0002172 high-affinity IgM receptor activity defines a precise molecular function at the interface of IgM recognition and intracellular signaling. The verified literature establishes FcμR as a high-affinity IgM receptor, identifies Ig alpha, Lyn, and Syk as proximal signaling components, and shows that antibody avidity shapes B cell fate decisions [1,4,6]. Related receptors such as the poly-Ig receptor and engineered FcγRI expand the biological and therapeutic relevance of Fc-mediated recognition [2,3]. For researchers, this term provides a robust ontological framework for designing binding assays, signaling experiments, and CRISPR-based functional genomics studies. EDITGENE supports these efforts with customizable cell models and screening services tailored to high-affinity IgM receptor activity research.
References
- 1. Nyamboya RA et al.. 2020. Mapping of the binding site for FcμR in human IgM-Fc.. Biochim Biophys Acta Proteins Proteom 1868(1):140266 PMID: 31449905
- 2. Phillips-Quagliata JM et al.. 2000. The IgA/IgM receptor expressed on a murine B cell lymphoma is poly-Ig receptor.. J Immunol 165(5):2544-55 PMID: 10946281
- 3. Farhat-Younis L et al.. 2024. Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity.. Elife 12 PMID: 38885133
- 4. Jugloff LS et al.. 1997. Cross-linking of the IgM receptor induces rapid translocation of IgM-associated Ig alpha, Lyn, and Syk tyrosine kinases to the membrane skeleton.. J Immunol 159(3):1096-106 PMID: 9233602
- 5. Andersson T et al.. 1996. Physiological activation of the IgH 3' enhancer in B lineage cells is not blocked by Pax-5.. Eur J Immunol 26(10):2499-507 PMID: 8898966
- 6. Udhayakumar V et al.. 1991. The influence of avidity on signaling murine B lymphocytes with monoclonal anti-IgM antibodies. Effects of B cell proliferation versus growth inhibition (tolerance) of an immature B cell lymphoma.. J Immunol 146(12):4120-9 PMID: 2040794
- 7. Kontny E. 1989. Surface markers on human activated T lymphocytes. I. Fc receptors for IgG and IgM.. Arch Immunol Ther Exp (Warsz) 37(5-6):557-68 PMID: 2535040
